ERBITUX CETUXIMAB Trademark

Trademark Overview

On Tuesday, September 10, 2002, a trademark application was filed for ERBITUX CETUXIMAB with the United States Patent and Trademark Office. The USPTO has given the ERBITUX CETUXIMAB trademark a serial number of 76463019. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 10, 2014. This trademark is owned by ImClone Systems Incorporated. The ERBITUX CETUXIMAB trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATION, NAMELY, MONOCLONAL ANTIBODY FOR THE TREATMENT OF CANCER
erbitux cetuximab

General Information

Serial Number76463019
Word MarkERBITUX CETUXIMAB
Filing DateTuesday, September 10, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 10, 2014
Registration Number3392234
Registration DateTuesday, March 4, 2008
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 29, 2003

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"CETUXIMAB"
Description of MarkThe mark comprises the words ERBITUX CETUXIMAB and an antibody design (shown in stippling).
Goods and ServicesPHARMACEUTICAL PREPARATION, NAMELY, MONOCLONAL ANTIBODY FOR THE TREATMENT OF CANCER
Lining/Stippling StatementThe stippling is for shading purposes.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 10, 2014
Primary Code005
First Use Anywhere DateThursday, February 19, 2004
First Use In Commerce DateThursday, February 19, 2004

Trademark Owner History

Party NameImClone Systems Incorporated
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014
Party NameImClone Systems Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10014
Party NameImClone Systems Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Trademark Events

Event DateEvent Description
Friday, October 10, 2014CANCELLED SEC. 8 (6-YR)
Wednesday, June 3, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 3, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 4, 2009ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, March 21, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 4, 2008REGISTERED-PRINCIPAL REGISTER
Monday, January 28, 2008LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, January 25, 2008ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, January 25, 2008EXAMINERS AMENDMENT MAILED
Thursday, January 24, 2008EXAMINER'S AMENDMENT ENTERED
Thursday, January 24, 2008SU-EXAMINER'S AMENDMENT WRITTEN
Wednesday, December 26, 2007EXAMINERS AMENDMENT MAILED
Saturday, December 22, 2007EXAMINER'S AMENDMENT ENTERED
Friday, December 21, 2007SU-EXAMINER'S AMENDMENT WRITTEN
Tuesday, December 18, 2007NON-FINAL ACTION MAILED
Monday, December 17, 2007SU - NON-FINAL ACTION - WRITTEN
Wednesday, October 31, 2007AMENDMENT FROM APPLICANT ENTERED
Wednesday, October 31, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 31, 2007ASSIGNED TO LIE
Tuesday, September 25, 2007PAPER RECEIVED
Wednesday, September 5, 2007NON-FINAL ACTION MAILED
Tuesday, September 4, 2007SU - NON-FINAL ACTION - WRITTEN
Friday, August 10, 2007STATEMENT OF USE PROCESSING COMPLETE
Friday, June 8, 2007USE AMENDMENT FILED
Friday, June 8, 2007PAPER RECEIVED
Tuesday, June 5, 2007ASSIGNED TO EXAMINER
Tuesday, April 10, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 20, 2007OPPOSITION TERMINATED NO. 999999
Wednesday, November 29, 2006PAPER RECEIVED
Thursday, November 6, 2003OPPOSITION INSTITUTED NO. 999999
Tuesday, April 29, 2003PUBLISHED FOR OPPOSITION
Wednesday, April 9, 2003NOTICE OF PUBLICATION
Friday, February 21, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 21, 2003ASSIGNED TO EXAMINER

Related Keywords

cetuximab erbitux treatment cancer antibody monoclonal preparation namely pharmaceutical